Yubo International Biotech Limited
YBGJ · OTC
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $3 | $104 | $1,244 | $1,354 |
| % Growth | -96.7% | -91.6% | -8.1% | – |
| Cost of Goods Sold | $213 | $52 | $424 | $114 |
| Gross Profit | -$209 | $53 | $821 | $1,240 |
| % Margin | -6,031% | 50.5% | 65.9% | 91.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,248 | $1,037 | $1,311 | $540 |
| SG&A Expenses | $1,248 | $1,047 | $1,493 | $1,201 |
| Sales & Mktg Exp. | $0 | $10 | $182 | $661 |
| Other Operating Expenses | $313 | $211 | $871 | $751 |
| Operating Expenses | $1,561 | $1,258 | $2,364 | $1,951 |
| Operating Income | -$1,770 | -$1,205 | -$1,543 | -$712 |
| % Margin | -51,006.3% | -1,155.7% | -124% | -52.6% |
| Other Income/Exp. Net | -$212 | $0 | $0 | -$0 |
| Pre-Tax Income | -$1,982 | -$1,205 | -$1,542 | -$712 |
| Tax Expense | -$206 | -$0 | -$0 | $0 |
| Net Income | -$1,775 | -$1,205 | -$1,542 | -$712 |
| % Margin | -51,161.5% | -1,155.3% | -123.9% | -52.6% |
| EPS | -0.015 | -0.01 | -0.013 | -0.006 |
| % Growth | -46.5% | 22.9% | -118.3% | – |
| EPS Diluted | -0.015 | -0.01 | -0.013 | -0.006 |
| Weighted Avg Shares Out | 119,821 | 118,721 | 118,131 | 118,178 |
| Weighted Avg Shares Out Dil | 119,821 | 118,721 | 118,131 | 118,178 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $427,000 | $0 |
| Depreciation & Amortization | $183 | $28 | $21 | $13 |
| EBITDA | -$1,799 | -$1,178 | -$1,521 | -$699 |
| % Margin | -51,831.2% | -1,129.3% | -122.3% | -51.6% |